Sign up to save your podcasts
Or
Share Operationalizing Cell and Gene Therapy Trials
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Operationalizing Cell and Gene Therapy Trials
In the third and final episode, Desmond Cabrera, global lead for cell and gene therapy at Allucent, shares how small- and mid-sized companies can operationalize cell and gene therapy trials.
View all episodes
By Industry Dive's studioIDIn the third and final episode, Desmond Cabrera, global lead for cell and gene therapy at Allucent, shares how small- and mid-sized companies can operationalize cell and gene therapy trials.